---
figid: PMC9608206__jcav13p3434g003
figtitle: Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR
  pathway in progression and treatment of non-small cell lung cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Arabidopsis thaliana
pmcid: PMC9608206
filename: jcav13p3434g003.jpg
figlink: /pmc/articles/PMC9608206/figure/F3/
number: F3
caption: PD-1/PD-L1 regulates PI3K pathway. The PD-1/PD-L1 regulates a number of functions
  of PI3K pathway. Both the transmembrane part and intracellular part of the PD-1/PD-L1
  pathway participate in this process. Reactions can happen in both immune cells and
  tumor cells. Arrows mean activation, and bars mean inhibition. While dotted lines
  represent PD-L1 expression. In tumor cells, after PD-L1 mRNA translation, cell-intrinsic
  PD-L1 activates Protein Kinase B (AKT). After PD-1/PD-L1 binding, Src homology-2-containing
  protein tyrosine phosphatase 2(SHP2) promotes Phosphatase and tensin homolog (PTEN)
  phosphorylation through working on casein kinase 2(CK2), further promoting phosphatidylinositol
  3, 4, 5-trisphosphate (PIP3) to generate phosphatidylinositol 4, 5-bisphosphate
  (PIP2).
papertitle: Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR
  pathway in progression and treatment of non-small cell lung cancer.
reftext: Zihan Quan, et al. J Cancer. 2022;13(13):3434-3443.
year: '2022'
doi: 10.7150/jca.77619
journal_title: Journal of Cancer
journal_nlm_ta: J Cancer
publisher_name: Ivyspring International Publisher
keywords: PD-1/PD-L1 | PI3K/AKT/mTOR pathway | Inhibitors | immunotherapy
automl_pathway: 0.9502438
figid_alias: PMC9608206__F3
figtype: Figure
redirect_from: /figures/PMC9608206__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9608206__jcav13p3434g003.html
  '@type': Dataset
  description: PD-1/PD-L1 regulates PI3K pathway. The PD-1/PD-L1 regulates a number
    of functions of PI3K pathway. Both the transmembrane part and intracellular part
    of the PD-1/PD-L1 pathway participate in this process. Reactions can happen in
    both immune cells and tumor cells. Arrows mean activation, and bars mean inhibition.
    While dotted lines represent PD-L1 expression. In tumor cells, after PD-L1 mRNA
    translation, cell-intrinsic PD-L1 activates Protein Kinase B (AKT). After PD-1/PD-L1
    binding, Src homology-2-containing protein tyrosine phosphatase 2(SHP2) promotes
    Phosphatase and tensin homolog (PTEN) phosphorylation through working on casein
    kinase 2(CK2), further promoting phosphatidylinositol 3, 4, 5-trisphosphate (PIP3)
    to generate phosphatidylinositol 4, 5-bisphosphate (PIP2).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - PTPN11
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - MTOR
  - RPTOR
  - RPS6KB1
  - RPS6KB2
  - Akt1
  - Pik3r1
  - Csnk2a1
  - Csnk2a2
  - Ptpn11
  - Pdcd1
  - Cd274
  - Rps6kb1
  - PIP3
  - VPS34
  - PIP2A
  - SHP2
  - PD1
---
